Penumbra Inc

Отворен

СекторЗдравеопазване

324.17 0.13

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

322.7

Максимум

324.57

Ключови измерители

By Trading Economics

Приходи

2.2M

35M

Продажби

15M

390M

P/E

Средно за сектора

80.584

57.371

EPS

0.88

Марж на печалбата

8.925

Служители

4,700

EBITDA

5.5M

52M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+10.22% upside

Дивиденти

By Acuity

Следващи печалби

4.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

321M

13B

Предишно отваряне

324.04

Предишно затваряне

324.17

Настроения в новините

By Acuity

50%

50%

147 / 340 Класиране в Healthcare

Penumbra Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.08.2026 г., 00:02 ч. UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

21.08.2026 г., 23:31 ч. UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

17.08.2026 г., 19:36 ч. UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

10.08.2026 г., 19:36 ч. UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

8.08.2026 г., 00:02 ч. UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

7.08.2026 г., 19:56 ч. UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

6.08.2026 г., 19:36 ч. UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

5.08.2026 г., 21:03 ч. UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

4.08.2026 г., 19:36 ч. UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

3.08.2026 г., 21:01 ч. UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

24.07.2026 г., 16:36 ч. UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Сравнение с други в отрасъла

Ценова промяна

Penumbra Inc Прогноза

Ценова цел

By TipRanks

10.22% нагоре

12-месечна прогноза

Среден 358.4 USD  10.22%

Висок 374 USD

Нисък 320 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Penumbra Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

6 ratings

1

Купи

5

Задържане

0

Продай

Настроение

By Acuity

147 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat